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Role Physical) compared to a 9-point increase in I-QOL
total score. Those with a 25% decrease in incontinent
episodes had improvements ranging from 0 (General
Health) to 5 points (Physical Functioning) compared to a
10-point improvement in the I-QOL score. Those that
self-reported “a little” improvement in their urinary con-
dition had improvements of 6 points on the I-QOL and
-1 to 2 in 7 of the 8 subscales of the SF-36. CONCLU-
SION: In a clinical trial, condition-speciﬁc measures 
can provide greater sensitivity and offer a clearer 
interpretation.
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OBJECTIVES: Dialysis patients have a chronic renal
insufﬁciency. For these patients process characteristics of
their treatment are important. Therefore this study aimed
at the development and testing of a questionnaire to
assess the quality of care in Dutch dialysis centers from
the patients perspective: the Quality of Care in Dialysis
centers (QCD) questionnaire. METHODS: In a literature
study possible sets of dimensions were identiﬁed. Four
focus group sessions were organized, with 27 patients in
total. The results from the focus groups were transformed
into a 68-item test version of the QCD. This version was
discussed with four nephrologists and seven patients. A
‘visual analogue scale’ (VAS) was added to determine
overall satisfaction. The ﬁnal test version was sent to 300
patients in a postal setting. Factor analysis was applied
and item reductions were conducted. RESULTS: Statisti-
cal analyses was based on 140 out of the 162 returned
questionnaires. The results from the factor analysis con-
ﬁrmed the use of the set of dimensions with the dimen-
sions: doctors, nurses, other staff members, and facilities.
The test version of the QCD instrument, was found to be
both construct valid and content valid. The instrument is
reliable, with Cronbach’s alpha of a = 0.91, a = 0.86, a
= 0.85 and a = 0.83 for four factors. After item reduc-
tion 36 items and the VAS remained. Each dimension con-
sists of 8 speciﬁc items and one item about the overall
satisfaction with that dimension. The 36-item QCD is
also content valid, construct valid and reliable (a = 0.83
and a = 0.84 for two factors). CONCLUSIONS: The
QCD can be used in Dutch dialysis centers. Further
research will be conducted to establish preference weights
per dimension on the basis of the VAS scores. These pref-
erence weights can be applied in benchmark procedures
to assess the quality of care in a dialysis center.
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OBJECTIVES: Prevalence rates of 16% have been
reported for overactive bladder (OAB). Despite the high
prevalence of overactive bladder (OAB), it is both an
under-diagnosed and underreported condition; less than
one half of community-dwelling persons with urinary
incontinence consult physicians about the problem. Once
symptoms develop many individuals explore treatment
options through a variety of channels depending on
symptom severity, perceived risk and the perceived value
gained from taking appropriate action. The purpose of
this study was to develop a self-administered question-
naire to measure perceived value for patients presenting
with symptoms of OAB. Psychometric evaluation of 
this questionnaire for scale development included item
development, item reduction and item analysis to assess
reliability and validity. METHODS: A questionnaire con-
sisting of 18 items was used for the study. Prior to inclu-
sion items were evaluated for both content and face
validity to ensure that they adequately represented the
value domain. The sample consisted of 50 patients from
a large clinic having symptoms of OAB. To be included,
participants were either male or female and were not
taking medications to treat their symptoms. Females had
to be pre-menopausal with no controls implemented for
hormone replacement therapy. Data were obtained via
telephone using trained interviewers. RESULTS: The
Kaiser-Meyer-Olkin (KMO) Measure of Sampling 
Adequacy for the ﬁnal principal components analysis 
was 0.774. The Bartlett Test of Sphericity was signiﬁcant
(0.0001), indicating the appropriate use of exploratory
factor analysis. Item reduction was accomplished by
examining item to total correlations and factor loadings.
Oblique rotation was used to obtain a ﬁnal factor solu-
tion consisting of four items, which explained 60% of the
variance. Cronbach’s alpha was 0.78 for the value scale.
CONCLUSIONS: A scale to assess perceived value was
developed that after undergoing psychometric evaluation
satisﬁed the criteria for scale reliability and validity.
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Urinary incontinence (UI) is a multi-faceted disease that
may signiﬁcantly impact patients’ daily lives and health-
related quality of life (HRQoL). Most recently, a number
of measures applying various approaches have been
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developed to assess patient-reported outcomes (PROs) in
UI. However, a comprehensive and critical review of these
measures has not been performed to date. OBJECTIVE:
To analyze and compare UI-speciﬁc PRO measures with
respect to content, psychometric properties and feasibil-
ity for use in clinical trials. METHODS: A systematic lit-
erature review, for the years 1985–2002, was performed
using Medline and Olga databases to identify PRO mea-
sures for UI; abstracts presented at various conferences
were also searched. Measures were characterized by
PROs (symptoms, activity limitation, HRQoL) and those
that were well-validated and/or frequently used were
selected for a detailed review. RESULTS: Twenty-two
PRO measures used in UI were identiﬁed, of these 8 were
selected for a detailed review. Six of the eight instruments
have been well-validated and six of them have been used
previously in clinical trials. Symptom-speciﬁc instruments
include: the Symptom Severity Index, Symptom Impact
Index, and Symptom Frequency and Bothersomeness
Scale. The Scale for Activity Interference and Limitations
captures activity limitation, speciﬁcally. The Incontinence
Quality of Life Questionnaire, Incontinence Impact Ques-
tionnaire, King’s Health Questionnaire, and Overactive
Bladder Questionnaire capture both activity limitation
and HRQoL; the latter two also contain items that assess
symptoms. A detailed review and comparison of con-
trasting attributes of the eight UI instruments, along with
psychometric properties, will be presented. CONCLU-
SION: Numerous UI-speciﬁc PRO measures are available.
Selection for use in clinical trials should be made based
on PROs of interest, relevance to patients, psychometric
properties, and feasibility of use.
